Hiroomi Tada

Insider Reports History

Entity
Individual
Location
C/O Tyra Biosciences, Inc, 2656 State Street, Carlsbad, CA
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hiroomi Tada:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tyra Biosciences, Inc. Chief Medical Officer Common Stock 86.4K $569K $6.58 Mar 15, 2024 Direct
Tyra Biosciences, Inc. Chief Medical Officer Stock Option (Right to Buy) 115K Jul 28, 2023 Direct

Insider Reports Filed by Hiroomi Tada

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TYRA Tyra Biosciences, Inc. Mar 15, 2024 1 $12.9K 4 Mar 19, 2024 Chief Medical Officer
TYRA Tyra Biosciences, Inc. Sep 15, 2023 1 $8.8K 4 Sep 19, 2023 Chief Medical Officer
TYRA Tyra Biosciences, Inc. Jul 28, 2023 1 $0 4 Aug 1, 2023 Chief Medical Officer
TYRA Tyra Biosciences, Inc. Mar 15, 2023 1 $12.5K 4 Mar 17, 2023 Chief Medical Officer
TYRA Tyra Biosciences, Inc. Sep 15, 2022 1 $4.69K 4 Sep 19, 2022 Chief Medical Officer
TYRA Tyra Biosciences, Inc. Sep 6, 2022 2 $23K 4 Sep 8, 2022 Chief Medical Officer
TYRA Tyra Biosciences, Inc. Nov 2, 2021 3 $0 4 Nov 4, 2021 Chief Medical Officer
TYRA Tyra Biosciences, Inc. Sep 14, 2021 0 $0 3 Sep 14, 2021 Chief Medical Officer